Prevalence of group B streptococcus colonization in Iranian pregnant women: A systematic review and meta-analysis
سال انتشار: 1398
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 329
نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
SRMMED22_141
تاریخ نمایه سازی: 19 آبان 1398
چکیده مقاله:
Background and Objective: Group B Streptococcus (GBS) is an important pathogen in newborns and pregnant women. The present study was carried out to estimate the prevalence of GBS colonization in pregnant women in Iran. Search Method: This systematic review and meta-analysis was based on Preferred Reporting Items for Systematic Reviews and Meta-Analysis guideline using the national databases including Society for Information Display, Magiran, Irandoc, Iran Medex, and international databases including MEDLINE, Web of Science, Scopus, PubMed, Science-Direct, Cochrane, Embase, Elton Bryson Stephens Company, Centre for Evidence-Based Medicine, Cumulative Index to Nursing and Allied re index was used to measu 2Health Literature, and Google Scholar, published by 01/30/2017. The Iheterogeneity between the studies. Findings: In a total of 667 documents, 30 (4.49%) were selected. In this study, the prevalence of GBS colonization in 10090 Iranian pregnant women was calculated as 13.65% [confidence interval (CI): 95%: 10.56-17.45]. Based on geographic region, 24.63% [CI: 95%: 11.52-45.06] in the West and 8.75% [CI: 95%: 6.43-11.8] in the East were the highest and lowest areas in Iran, respectively, and were statistically significant (p = 0.001). Also, with regards to swapping sampling area, Vaginal with 11.96%, Vaginal and Rectal with 13.62%, and Anal and Vaginal with 25.63% were the least to the greatest, respectively, and were statistically significant (p = 0.001). Conclusion: Therefore, based on the recommendation of Centers for Disease Control and Prevention as reported by the Ministry of Health and Medical education, early diagnosis, and screening of high-risk women should be done at 35-37 weeks of pregnancy.
کلیدواژه ها:
نویسندگان
Mohammad Hossein YektaKooshali
Student Research Committee, School of nursing, Midwifery and Paramedicine, Guilan University of Medical Sciences, Rasht, Iran.
Masoud Hamidi
Medical Biotechnology Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Mohammad Taghi Razavi Tousi
Medical Biotechnology Research Center, Guilan University of Medical Sciences, Rasht, Iran.
Iraj Nikokar
Medical Biotechnology Research Center, Guilan University of Medical Sciences, Rasht, Iran.